市場調查報告書
商品編碼
1424865
全球髖關節重建市場 - 市場規模(按細分市場)、份額、監管、報銷、手術、預測(~2033)Hip Reconstruction Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
由於醫院數量的增加、骨關節炎 (OA) 和類風濕性關節炎 (RA) 的 ASC 的流行以及創傷患者數量的增加,全世界對髖關節重建的需求正在增加。 這是因為髖關節重建被醫生用來診斷和簡化各種關節疾病和損傷的治療(滑膜炎、關節炎、韌帶/肌腱/軟骨撕裂等)。
髖關節重建裝置在美國和歐洲市場有著悠久的歷史,在亞太和南美等新興市場也很受歡迎。
本報告研究和分析了全球髖關節重建市場,並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。
市場模型的主要內容如下。
已上市的髖關節重建設備和不斷變化的競爭格局
全球、區域和國家層面的特定市場考量
透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息,使您能夠更深入地研究市場動態。
目標公司
Hip Reconstruction Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Hip Reconstruction Devices market for the year 2020 and beyond. The increasing of Hospitals, ASC's prevalence of osteoarthritis (OA) and rheumatoid arthritis (RA), and the growing number of trauma cases are driving an increased demand for Hip Reconstruction globally as they are used by physicians to simplify the diagnosis and/or treatment of an extensive variety of joint diseases and injuries (e.g., synovitis, arthritis, ligament/tendon/cartilage tears).
Hip Reconstruction devices have a long history of use in the US and European markets, and are well established in emerging markets such as APAC and South America.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Hip Reconstruction Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Zimmer Biomet Holdings Inc, Johnson & Johnson, Stryker Corp, Smith & Nephew Plc, B. Braun Melsungen AG, EQT Partners AB, MicroPort Scientific Corp, Medacta Group SA, Corin Orthopaedics Holdings Ltd, Exactech Inc, Kyocera Medical Technologies Inc, Baumer SA, Waldemar Link GmbH & Co KG, Amplitude Surgical SA, United Orthopedic Corp, Corentec Co Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable